Cordatus Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.86M Sell
32,150
-149
-0.5% -$34.7K 1.87% 11
2025
Q4
$6.68M Buy
32,299
+65
+0.2% +$12.9K 1.55% 13
2025
Q3
$5.98M Sell
32,234
-217
-0.7% -$37.2K 1.41% 14
2025
Q2
$4.96M Sell
32,451
-1,218
-4% -$187K 1.22% 17
2025
Q1
$5.58M Buy
33,669
+1,791
+6% +$280K 1.53% 16
2024
Q4
$4.61M Sell
31,878
-35
-0.1% -$5.42K 1.22% 21
2024
Q3
$5.17M Buy
31,913
+523
+2% +$83.3K 1.86% 12
2024
Q2
$4.59M Buy
+31,390
New +$4.67M 1.72% 13
2023
Q3
Sell
-32,417
Closed -$5.37M 104
2023
Q2
$5.37M Buy
+32,417
New +$5.23M 2.02% 8
2022
Q4
Sell
-20,349
Closed -$3.32M 76
2022
Q3
$3.32M Buy
20,349
+520
+3% +$88K 3.5% 6
2022
Q2
$3.52M Buy
19,829
+162
+0.8% +$28.9K 1.64% 6
2022
Q1
$3.48M Sell
19,667
-5,409
-22% -$920K 1.22% 10
2021
Q4
$4.29M Buy
+25,076
New +$4.11M 1.26% 15
2021
Q1
$2.85M Buy
17,312
+594
+4% +$96.1K 1.09% 20
2020
Q4
$2.63M Buy
16,718
+256
+2% +$37.8K 1.11% 21
2020
Q3
$2.45M Sell
16,462
-116
-0.7% -$17.2K 1.18% 18
2020
Q2
$2.33M Buy
16,578
+100
+0.6% +$14.6K 1.28% 20
2020
Q1
$2.16M Buy
16,478
+4,502
+38% +$639K 1.56% 17
2019
Q4
$1.75M Buy
11,976
+1,935
+19% +$262K 0.87% 44
2019
Q3
$1.3M Buy
10,041
+2,226
+28% +$293K 0.68% 54
2019
Q2
$1.09M Buy
7,815
+122
+2% +$16.9K 0.64% 51
2019
Q1
$1.07M Buy
7,693
+911
+13% +$122K 0.59% 59
2018
Q4
$875K Buy
+6,782
New +$946K 0.62% 45

Other funds holding JNJ

Cordatus Wealth Management's JNJ Position: Q1 2026 in Review

Cordatus Wealth Management reduced its Johnson & Johnson (JNJ) stake by 0.46% in Q1 2026, selling an estimated $34.7K and leaving 32,150 shares worth $7.86M. The position accounts for 1.87% of the portfolio, ranked #11.

Cordatus Wealth Management first reported a position in JNJ in Q4 2018 and has held it in 23 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cordatus Wealth Management held 32,150 shares of Johnson & Johnson worth $7.86M as of Q1 2026.
  • Cordatus Wealth Management sold 149 Johnson & Johnson shares in Q1 2026, an estimated $34.7K.
  • Johnson & Johnson made up 1.87% of Cordatus Wealth Management's portfolio in Q1 2026, its #11 holding.
  • Cordatus Wealth Management first reported a position in Johnson & Johnson in Q4 2018 and has held it in 23 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cordatus Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.